I want to start by thanking the witnesses for their informative remarks.
What worries me, as a medical practitioner, is of course the drug shortage. I do not know what I would say to a patient who came to me and whose critical drug was out of stock.
According to the Canadian Agency for Drugs and Technologies in Health, new Health Canada requirements, such as the policy for notifiable changes, have contributed to drug shortages.
Could you describe the new notifiable change policy to the committee? Do you agree that new requirements by your department can contribute to drug shortages, and why?